The apo forms of NCX3 splice variants predefine incremental changes in backbone dynamics upon Ca2+ binding, which may account for slower inactivation in skeletal versus brain-expressed variants.
Mammalian Na + /Ca 2+ exchangers, NCX1 and NCX3, generate splice variants, whereas NCX2 does not. The CBD1 and CBD2 domains form a regulatory tandem (CBD12), where Ca 2+ binding to CBD1 activates and Ca 2+ binding to CBD2 (bearing the splicing segment) alleviates the Na + -induced inactivation. Here, the NCX2-CBD12, NCX3-CBD12-B, and NCX3-CBD12-AC proteins were analyzed by small-angle X-ray scattering (SAXS) and hydrogen-deuterium exchange mass-spectrometry (HDX-MS) to resolve regulatory variances in the NCX2 and NCX3 variants. SAXS revealed the unified model, according to which the Ca 2+ binding to CBD12 shifts a dynamic equilibrium without generating new conformational states, and where more rigid conformational states become more populated without any global conformational changes. HDX-MS revealed the differential effects of the B and AC exons on the folding stability of apo CBD1 in NCX3-CBD12, where the dynamic differences become less noticeable in the Ca 2+ -bound state. Therefore, the apo forms predefine incremental changes in backbone dynamics upon Ca 2+ binding. These observations may account for slower inactivation (caused by slower dissociation of occluded Ca 2+ from CBD12) in the skeletal vs the brain-expressed NCX2 and NCX3 variants. This may have physiological relevance, since NCX must extrude much higher amounts of Ca 2+ from the skeletal cell than from the neuron.
No takes yet. Share an insight, caveat, or question.
Giladi et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: